Sell Doximity Into The Major Rally Following Its Q1 Results (NYSE:DOCS)
· seekingalpha.com
Doximity, Inc. stock surged 180% after Q1 FY27 and strong guidance. Click for more on DOCS and its big earnings release and see why I am bearish.
I've been investing for over a decade, with a primary focus on U.S. growth stocks, alongside coverage of UK-listed names. I'm particularly drawn to inflection p...